Ribomic (TSE:4591) EV-to-OCF: (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4591 Ribomic Inc TSE:4591
32 GF Score
Price 円77.00
! 3 Warning Signs
View Full Analysis

What is Ribomic EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Ribomic's Enterprise Value is 円1,480.88 Mil. Ribomic's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 円0.00 Mil. Therefore, Ribomic's EV-to-OCF for today is .

The historical rank and industry rank for Ribomic's EV-to-OCF or its related term are showing as below:

TSE:4591' s EV-to-OCF Range Over the Past 10 Years
Min: -1.23   Med: 0   Max: -1.23
Current: -1.23

During the past 13 years, the highest EV-to-OCF of Ribomic was -1.23. The lowest was -1.23. And the median was .

TSE:4591's EV-to-OCF is ranked worse than
62.47% of 1407 companies
in the Biotechnology industry
Industry Median: -3.54 vs TSE:4591: -1.23

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-13), Ribomic's stock price is 円77.00. Ribomic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-23.070. Therefore, Ribomic's PE Ratio (TTM) for today is At Loss.


Ribomic  (TSE:4591) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Ribomic's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=77.00/-23.070
=At Loss

Ribomic's share price for today is 円77.00.
Ribomic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-23.070.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Ribomic EV-to-OCF Related Terms


Ribomic EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Ribomic's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic EV-to-OCF Chart

Ribomic Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.86 -1.40 0.06 -1.34 -1.76

Ribomic Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.34 0.00 0.00 0.00 -1.76

TSE:4591 vs VRTX, REGN, RVMD: EV-to-OCF Comparison

For the Biotechnology subindustry, Ribomic's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ribomic EV-to-OCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ribomic's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Ribomic's EV-to-OCF falls into.


TSE:4591
32GF Score
Ribomic Inc TSE:4591
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ribomic EV-to-OCF Calculation

Ribomic's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=1480.879/0
=

Ribomic's current Enterprise Value is 円1,480.88 Mil.
Ribomic's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
32GF Score

Get the complete analysis for TSE:4591

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円77.00
Price